Associate Director/Director, Global HEOR Oncology AML Franchise in Bernards, NJ at DSI

Date Posted: 6/19/2018

Job Snapshot

Job Description

About Daiichi Sankyo Cancer Enterprise
The vision of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do. Anchored by three pillars including our investigational Antibody Drug Conjugate Franchise, Acute Myeloid Leukemia Franchise and Breakthrough Science Franchise, we aim to deliver seven distinct new molecular entities over eight years during 2018 to 2025. Our powerful research engines include two laboratories for biologic/immuno-oncology and small molecules in Japan, and Plexxikon Inc., our small molecule structure-guided R&D center in Berkeley, CA.

Job Summary:

The purpose of this job is to develop Global HEOR strategies for the assigned Oncology / AML Franchise products and execute global, comprehensive and scientifically rigorous HEOR activities for the assigned products, aligned with the global R&D, commercial and market access strategies, contributing to optimal pricing, reimbursement and market access.


  • Provision of HEOR strategic direction to project teams
Provide HEOR strategic direction to Global Project Teams (GPTs) and Global Brand Teams (GBTs) and provide recommendations on such aspects as appropriate comparators, target patient populations, clinical and economic end-points and patient-reported outcomes (PROs), ensuring the payer perspective is incorporated in the assigned clinical development programs and the evidence needed to support optimal market access is addressed. Contribute HEOR sections to target product profiles (TPPs), product development plans, clinical development plans, and commercialization plans and other critical documents.

  • Development of value propositions and execution and reporting of HEOR studies
Lead the development of global value propositions that differentiate the assigned products for health policy decision-makers, government & commercial payers, consumers and other stakeholders and identify the supporting evidence requirements, aligned with the GPTs, GBTs, Regional HEOR and Market Access functions.
Plan and conduct HEOR studies such as early economic models, burden of illness studies and the development and validation of patient-reported outcome (PRO) instruments and lead the preparation of global value dossiers which present the product value propositions and the supporting evidence, aligned with the product development strategies and endorsed by the GPTs, GBTs, Regional HEOR and market access, to realize an optimal value demonstration of the products.

  • HEOR scientific publications & communications
Develop HEOR communications (e.g. manuscripts, scientific forum presentations, slide kits, symposia), in collaboration with multi-functional teams, to build the peer reviewed published evidence supporting the value propositions for assigned products.
  • Vendor management
Effectively manage the entire process for projects outsourced to external consultancies and contractors, ensuring delivery according to key milestones, budget and to agreed and expected quality.

  • Internal Collaboration
Collaborate and communicate effectively with internal global/ regional functional peers and cross functional colleagues/ teams, share knowledge and provide input on global HEOR needs, to enhance effective functioning of the DS matrix structure as well as contributing to meet program objectives and global HEOR goals.

  • Knowledge of HEOR scientific methods and health policy environment
Maintain and continue to enhance knowledge about HEOR methods and the evolving public health policy and reimbursement environment in major (USA, Europe and Japan) and other pertinent markets.

Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.


  • Doctorate or Master’s degree in a relevant discipline (e.g., health economics, health services research, medicine, pharmacy, public health, psychometrics, epidemiology, and decision sciences)
  • Minimum of 5 years’ experience in the healthcare or pharmaceutical industry, 3 of which must be working in the health economics and outcomes research field.
  • Hands on experience with HEOR methodologies across all phases of the product life cycle is preferred.
  • Keen insight and track record of successful application of HEOR data with key external stakeholders in all major international markets is preferred.
  • Knowledge of Oncology therapy areas is preferred.
  • Drug development - Demonstrates understanding and (advanced) knowledge of key drug development processes, plans, studies, and strategies including the clinical, regulatory, scientific, operational, and commercial aspects of drug development. Uses knowledge to the organization’s advantage; generates new ideas and enables the organization to improve business performance
  • HEOR scientific knowledge - Demonstrates understanding and (advanced) knowledge of HEOR methods and study designs, and the issues and challenges of applying these alongside clinical studies and in drug development. Applies this knowledge to design HEOR strategies and studies and solve problems.
  • Knowledge of industry and policy environment - Demonstrates deep understanding of the commercial and market access policy environment across major markets and harnesses this knowledge to design effective HEOR evidence development strategies to support optimal market/patient access for Daiichi Sankyo medicines.
  • Influencing Skills
  • Stakeholder management
  • Team leadership
  • Strategic thinking

Ability to travel up to 10%

Compensation and seniority level/title will be commensurate with experience and qualifications. Duties and responsibilities may vary based on the position level/title.

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.